These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8566211)
1. A herpes simplex virus vector overexpressing the glucose transporter gene protects the rat dentate gyrus from an antimetabolite toxin. Dash R; Lawrence M; Ho D; Sapolsky R Exp Neurol; 1996 Jan; 137(1):43-8. PubMed ID: 8566211 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. Lawrence MS; Sun GH; Kunis DM; Saydam TC; Dash R; Ho DY; Sapolsky RM; Steinberg GK J Cereb Blood Flow Metab; 1996 Mar; 16(2):181-5. PubMed ID: 8594048 [TBL] [Abstract][Full Text] [Related]
3. Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults. Ho DY; Saydam TC; Fink SL; Lawrence MS; Sapolsky RM J Neurochem; 1995 Aug; 65(2):842-50. PubMed ID: 7616244 [TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss. Lawrence MS; Ho DY; Dash R; Sapolsky RM Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7247-51. PubMed ID: 7638175 [TBL] [Abstract][Full Text] [Related]
5. Delivery of herpes simplex virus amplicon-based vectors to the dentate gyrus does not alter hippocampal synaptic transmission in vivo. Dumas T; McLaughlin J; Ho D; Meier T; Sapolsky R Gene Ther; 1999 Oct; 6(10):1679-84. PubMed ID: 10516716 [TBL] [Abstract][Full Text] [Related]
6. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. Lawrence MS; McLaughlin JR; Sun GH; Ho DY; McIntosh L; Kunis DM; Sapolsky RM; Steinberg GK J Cereb Blood Flow Metab; 1997 Jul; 17(7):740-4. PubMed ID: 9270490 [TBL] [Abstract][Full Text] [Related]
7. Gene therapies that enhance hippocampal neuron survival after an excitotoxic insult are not equivalent in their ability to maintain synaptic transmission. Dumas TC; McLaughlin JR; Ho DY; Lawrence MS; Sapolsky RM Exp Neurol; 2000 Nov; 166(1):180-9. PubMed ID: 11031094 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
9. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Ho DY; Mocarski ES; Sapolsky RM Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3655-9. PubMed ID: 8386379 [TBL] [Abstract][Full Text] [Related]
10. Expression of the lacZ reporter gene in the rat basal forebrain, hippocampus, and nigrostriatal pathway using a nonreplicating herpes simplex vector. Maidment NT; Tan AM; Bloom DC; Anton B; Feldman LT; Stevens JG Exp Neurol; 1996 May; 139(1):107-14. PubMed ID: 8635556 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiology and immunohistochemistry in the hippocampal ca1 and the dentate gyrus of rats chronically exposed to 1-bromopropane, a substitute for specific chlorofluorocarbons. Fueta Y; Fukuda T; Ishidao T; Hori H Neuroscience; 2004; 124(3):593-603. PubMed ID: 14980730 [TBL] [Abstract][Full Text] [Related]
12. An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid. Fink SL; Ho DY; McLaughlin J; Sapolsky RM Brain Res; 2000 Mar; 859(1):21-5. PubMed ID: 10720611 [TBL] [Abstract][Full Text] [Related]
13. Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Kelly S; Zhang ZJ; Zhao H; Xu L; Giffard RG; Sapolsky RM; Yenari MA; Steinberg GK Ann Neurol; 2002 Aug; 52(2):160-7. PubMed ID: 12210785 [TBL] [Abstract][Full Text] [Related]
14. Potential and limitations of a gamma 34.5 mutant of herpes simplex 1 as a gene therapy vector in the CNS. McMenamin MM; Byrnes AP; Pike FG; Charlton HM; Coffin RS; Latchman DS; Wood MJ Gene Ther; 1998 May; 5(5):594-604. PubMed ID: 9797863 [TBL] [Abstract][Full Text] [Related]
15. BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia. Antonawich FJ; Federoff HJ; Davis JN Exp Neurol; 1999 Mar; 156(1):130-7. PubMed ID: 10192784 [TBL] [Abstract][Full Text] [Related]
16. HSV-mediated delivery of virally derived anti-apoptotic genes protects the rat hippocampus from damage following excitotoxicity, but not metabolic disruption. Roy M; Hom JJ; Sapolsky RM Gene Ther; 2002 Feb; 9(3):214-9. PubMed ID: 11859425 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective potential of a viral vector system induced by a neurological insult. Ozawa CR; Ho JJ; Tsai DJ; Ho DY; Sapolsky RM Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9270-5. PubMed ID: 10908682 [TBL] [Abstract][Full Text] [Related]
18. Long-term expression driven by herpes simplex virus type-1 amplicons may fail due to eventual degradation or extrusion of introduced transgenes. Tsai DJ; Ho JJ; Ozawa CR; Sapolsky RM Exp Neurol; 2000 Sep; 165(1):58-65. PubMed ID: 10964485 [TBL] [Abstract][Full Text] [Related]
19. Herpes simplex viral and amplicon vector-mediated gene transfer into glia and neurons in organotypic spinal cord and dorsal root ganglion cultures. Marsh DR; Dekaban GA; Tan W; Strathdee CA; Weaver LC Mol Ther; 2000 May; 1(5 Pt 1):464-78. PubMed ID: 10933968 [TBL] [Abstract][Full Text] [Related]